Evaluation of the Benefit Provided by Acupuncture During a Surgery of Deep Brain Stimulation (ACUplus)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02236260 |
Recruitment Status :
Completed
First Posted : September 10, 2014
Last Update Posted : September 7, 2017
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Parkinson's Disease | Procedure: Electroacupuncture Drug: Local Anesthesia (lidocaine hydrochloride) | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 20 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Supportive Care |
Official Title: | Evaluation of the Benefit Provided by the Addition of Acupunctural Analgesia With Electrostimulation to Conventional Local Anesthesia Compared to Conventional Local Anesthesia Alone in Surgery of Deep Brain Stimulation for Movement Disorders. |
Actual Study Start Date : | September 3, 2014 |
Actual Primary Completion Date : | June 12, 2017 |
Actual Study Completion Date : | June 14, 2017 |

Arm | Intervention/treatment |
---|---|
Active Comparator: Local anesthesia alone |
Drug: Local Anesthesia (lidocaine hydrochloride)
All patients will receive injectable paracetamol for pain relief, a mix of nitrous oxide 50% and oxygen 50% for analgesia and lidocaine hydrochloride for local anesthesia. |
Experimental: Local Anesthesia + Electroacupuncture |
Procedure: Electroacupuncture
Acupuncture will be performed using an electrical stimulator (generating electrical stimulation) for electroacupuncture. Drug: Local Anesthesia (lidocaine hydrochloride) All patients will receive injectable paracetamol for pain relief, a mix of nitrous oxide 50% and oxygen 50% for analgesia and lidocaine hydrochloride for local anesthesia. |
- Patient comfort, judged by "Edmonton Symptom Assessment System" scale (ESAS) [ Time Frame: The day of the DBS procedure ]
- Patient anxiety, judged by Hamilton anxiety scale (HAMA) [ Time Frame: The day before the DBS procedure, the day of the DBS procedure, 2 days after the DBS procedure ]
- Drug consumption [ Time Frame: The day of the DBS procedure, 2 days after the DBS procedure ]
- Anesthesia monitoring parameters: heart rate, blood pressure, pulse oximetry [ Time Frame: The day of the DBS procedure, 2 days after the DBS procedure ]Composite measure
- Adverse effects [ Time Frame: The day before the DBS procedure,the day of the DBS procedure, 2 days after the DBS procedure ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 74 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Patients from both sexes aged who are >= 18 years
- Disabling movement disorders, resistant to medical treatment, in Parkinson's patients who should benefit from a Deep Brain Stimulation in the subthalamic nucleus
- Scheduled intervention of a Deep Brain Stimulation
- Understanding of acupunctural analgesia with electrostimulation
- Signed informed consent
- Membership to a social security insurance scheme
Exclusion Criteria:
- Patients who are >= 75 years
- History of intolerance to acupuncture
- Contraindications to local anesthesia
- Respiratory problems (asthma, COPD, ...)
- Holder of an implanted pacemaker
- Obesity with BMI > 30
- History of motion sickness
- Unstabilized psychiatric disorders
- Impaired cognitive functions
- Pregnancy
- Breastfeeding
- Minors
- Major under a legal protection regime

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02236260
France | |
Centre Hospitalier Universitaire de Nantes | |
Nantes, France, 44000 |
Principal Investigator: | Sylvie RAOUL, MD | Nantes University Hospital |
Responsible Party: | Nantes University Hospital |
ClinicalTrials.gov Identifier: | NCT02236260 |
Other Study ID Numbers: |
RC14_0060 |
First Posted: | September 10, 2014 Key Record Dates |
Last Update Posted: | September 7, 2017 |
Last Verified: | September 2017 |
Parkinson Disease Parkinsonian Disorders Basal Ganglia Diseases Brain Diseases Central Nervous System Diseases Nervous System Diseases Movement Disorders Synucleinopathies Neurodegenerative Diseases Lidocaine Anesthetics, Local |
Anesthetics Central Nervous System Depressants Physiological Effects of Drugs Sensory System Agents Peripheral Nervous System Agents Anti-Arrhythmia Agents Voltage-Gated Sodium Channel Blockers Sodium Channel Blockers Membrane Transport Modulators Molecular Mechanisms of Pharmacological Action |